Inhibition of murine macrophage nitric oxide synthase expression by a pivoxil prodrug of antiviral acyclic nucleotide analogue 9-(2-phosphonomethoxyethyl)adenine.

[1]  C. Perno,et al.  Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines. , 1996, Molecular pharmacology.

[2]  E. De Clercq,et al.  Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems. , 1996, Biochemical and biophysical research communications.

[3]  J. Corbett,et al.  Regulation of Inducible Nitric Oxide Synthase Expression by Macrophage Purinoreceptors and Calcium (*) , 1996, The Journal of Biological Chemistry.

[4]  E. De Clercq,et al.  Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine , 1996, Antimicrobial agents and chemotherapy.

[5]  A. Zidek,et al.  Suppression of rat adjuvant arthritis by some acyclic nucleotide analogs. , 1995, European journal of pharmacology.

[6]  U. Förstermann,et al.  Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. , 1995, Biochemical pharmacology.

[7]  C. Perno,et al.  Phosphorylation of 9-(2-phosphonyimethoxyethyl)adenine (PMEA) is greater in macrophages than in replicating lymphocytes and fibroblasts , 1995 .

[8]  S Moncada,et al.  Nitric oxide synthases in mammals. , 1994, The Biochemical journal.

[9]  Y. Vodovotz,et al.  Mechanism of suppression of nitric oxide synthase expression by interleukin‐4 in primary mouse macrophages , 1994, Journal of leukocyte biology.

[10]  E. De Clercq,et al.  Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs , 1993, Antimicrobial Agents and Chemotherapy.

[11]  M. Connelly,et al.  Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates , 1993, Antimicrobial Agents and Chemotherapy.

[12]  S. Gross,et al.  Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. , 1992, The Journal of biological chemistry.

[13]  C. Nathan,et al.  Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  J. C. Martin,et al.  Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine. , 1992, Antiviral research.

[15]  Terry D. Lee,et al.  Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. , 1992, Science.

[16]  F. Murad,et al.  Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. , 1992, Molecular pharmacology.

[17]  C. Nathan,et al.  Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. De Clercq,et al.  Cellular uptake of phosphonylmethoxyalkylpurine derivatives. , 1991, Antiviral research.

[19]  E. De Clercq,et al.  Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Werner,et al.  Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts , 1990, The Journal of experimental medicine.

[21]  J. Vlach,et al.  Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro. , 1990, Antiviral research.

[22]  I. Votruba,et al.  Inhibition of avian myeloblastosis virus reverse transcriptase by diphosphates of acyclic phosphonylmethyl nucleotide analogues. , 1990, Antiviral research.

[23]  E. De Clercq,et al.  Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo , 1989, Antimicrobial Agents and Chemotherapy.

[24]  M. Marletta,et al.  Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. , 1988, Biochemistry.

[25]  E. De Clercq,et al.  Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents , 1988, Antimicrobial Agents and Chemotherapy.

[26]  J. Hibbs,et al.  SHORT COMMUNICATION: Cytokines Induce an L‐Arginine‐Dependent Effector System in Nonmacrophage Cells , 1988, Journal of leukocyte biology.

[27]  E. De Clercq,et al.  Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines. , 1987, Antiviral research.

[28]  M. Marletta,et al.  Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. , 1987, Journal of immunology.

[29]  J. Balzarini,et al.  A novel selective broad-spectrum anti-DNA virus agent , 1986, Nature.

[30]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[31]  L. Naesens,et al.  IN VIVO ANTIRETROVIRAL EFFICACY OF ORAL BIS(POM)-PMEA, THE BIS(PIVALOYLOXYMETHYL)PRODRUG OF 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE (PMEA) , 1995 .

[32]  A. Holý,et al.  Synthesis of 9-(2-Phosphinomethoxyethyl)adenine and Related Compounds , 1987 .